Correlation Between Cytokinetics and Allovir

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cytokinetics and Allovir at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytokinetics and Allovir into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cytokinetics and Allovir, you can compare the effects of market volatilities on Cytokinetics and Allovir and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytokinetics with a short position of Allovir. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytokinetics and Allovir.

Diversification Opportunities for Cytokinetics and Allovir

0.88
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Cytokinetics and Allovir is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Cytokinetics and Allovir in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allovir and Cytokinetics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytokinetics are associated (or correlated) with Allovir. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allovir has no effect on the direction of Cytokinetics i.e., Cytokinetics and Allovir go up and down completely randomly.

Pair Corralation between Cytokinetics and Allovir

Given the investment horizon of 90 days Cytokinetics is expected to generate 0.74 times more return on investment than Allovir. However, Cytokinetics is 1.36 times less risky than Allovir. It trades about 0.07 of its potential returns per unit of risk. Allovir is currently generating about -0.01 per unit of risk. If you would invest  1,565  in Cytokinetics on July 4, 2022 and sell it today you would earn a total of  3,280  from holding Cytokinetics or generate 209.58% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Cytokinetics  vs.  Allovir

 Performance (%) 
       Timeline  
Cytokinetics 
Cytokinetics Performance
4 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Cytokinetics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, Cytokinetics demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Cytokinetics Price Channel

Allovir 
Allovir Performance
11 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Allovir are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Allovir reported solid returns over the last few months and may actually be approaching a breakup point.

Allovir Price Channel

Cytokinetics and Allovir Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cytokinetics and Allovir

The main advantage of trading using opposite Cytokinetics and Allovir positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytokinetics position performs unexpectedly, Allovir can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will offset losses from the drop in Allovir's long position.
Cytokinetics vs. Osg Corp
Cytokinetics vs. Yue Yuen Industrial
Cytokinetics vs. RBC Bearings Incorporated
Cytokinetics vs. Misumi Group
The idea behind Cytokinetics and Allovir pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Allovir vs. RLX Technology
Allovir vs. British American Tob
Allovir vs. British American Tobacco
Allovir vs. Scandinavian Tob Group
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go